<DOC>
	<DOC>NCT01652118</DOC>
	<brief_summary>The purpose of this study is to determine of clarithromycin effect on developing of bronchopulmonary dysplasia in preterm babies.</brief_summary>
	<brief_title>Clarithromycin Prophylaxis in Preterm Infants Colonisation With Ureaplasma Urealyticum and Mycoplasma Hominis</brief_title>
	<detailed_description>The investigators planned that clarithromycin treatment in preterm babies who are under 1250 grams birth weight. The investigators aimed with this treatment, the bronchopulmonary dysplasia rate of preterm babies may decrease.</detailed_description>
	<mesh_term>Bronchopulmonary Dysplasia</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<criteria>all infant must be under 1250 gram birth weight Major congenital anomaly, CardiaC abnormality, without inform consent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>2 Days</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>bronchopulmonary dysplasia</keyword>
	<keyword>clarithromycin</keyword>
	<keyword>preterm babies</keyword>
</DOC>